Quinaprilat

Quinaprilat
Clinical data
Other names	CI-928
ATC code	None;
Identifiers
	IUPAC name (3S)-2-(1S)-1-carboxy-3-phenylpropylaminopropanoyl-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;
CAS Number	82768-85-2;
IUPHAR/BPS	6352;
ChemSpider	97106;
UNII	34SSX5LDE5;
ChEMBL	ChEMBL1733;
CompTox Dashboard (EPA)	DTXSID40868904 ;
Chemical and physical data
Formula	C23H26N2O5
Molar mass	410.470 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC@@H(C(=O)N1CC2=CC=CC=C2CC@H1C(=O)O)NC@@H(CCC3=CC=CC=C3)C(=O)O;
	InChI InChI=1S/C23H26N2O5/c1-15(24-19(22(27)28)12-11-16-7-3-2-4-8-16)21(26)25-14-18-10-6-5-9-17(18)13-20(25)23(29)30/h2-10,15,19-20,24H,11-14H2,1H3,(H,27,28)(H,29,30)/t15-,19-,20-/m0/s1; Key:FLSLEGPOVLMJMN-YSSFQJQWSA-N;

Quinaprilat is the active metabolite of quinapril.^[1]

Referencesedit

^ Ferry JJ, Horvath AM, Sedman AJ, Latts JR, Colburn WA (1987). "Influence of food on the pharmacokinetics of quinapril and its active diacid metabolite, CI-928". Journal of Clinical Pharmacology. 27 (5): 397–9. doi:10.1002/j.1552-4604.1987.tb03037.x. PMID 3693584. S2CID 36546103.

This antihypertensive-related article is a stub. You can help Wikipedia by expanding it.

Zdroj:https://en.wikipedia.org?pojem=Quinaprilat
Text je dostupný za podmienok Creative Commons Attribution/Share-Alike License 3.0 Unported; prípadne za ďalších podmienok. Podrobnejšie informácie nájdete na stránke Podmienky použitia.

[1] Ferry JJ, Horvath AM, Sedman AJ, Latts JR, Colburn WA (1987). "Influence of food on the pharmacokinetics of quinapril and its active diacid metabolite, CI-928". Journal of Clinical Pharmacology. 27 (5): 397–9. doi:10.1002/j.1552-4604.1987.tb03037.x. PMID 3693584. S2CID 36546103.

[1]

v t e Antihypertensive drugs acting on the renin–angiotensin system (C09)
ACE inhibitors ("-pril")	Sulfhydryl-containing: Captopril Rentiapril Zofenopril Dicarboxylate-containing: Enalapril^# Benazepril Cilazapril Delapril Imidapril Lisinopril (+amlodipine, +HCT) Moexipril Perindopril (+indapamide) Quinapril (+HCT) Ramipril Spirapril Temocapril Trandolapril Phosphonate-containing: Ceronapril Fosinopril (+HCT) Other/ungrouped: Alacepril
AIIRAs ("-sartan")	Azilsartan Candesartan Eprosartan Fimasartan Irbesartan (+HCT) Losartan (+HCT) Olmesartan (+amlodipine, +amlodipine and HCT, +HCT) Tasosartan^§ Telmisartan (+amlodipine, +HCT) Valsartan (+amlodipine, +amlodipine and HCT, +HCT, +nebivolol)
Renin inhibitors ("-kiren")	Aliskiren (+amlodipine, +HCT, +amlodipine and HCT) Remikiren^§
Dual ACE/NEP inhibitors	Gemopatrilat Ilepatril Omapatrilat Sampatrilat
Neprilysin inhibitors	Sacubitril (+valsartan)
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III